Philip Ma is the founder of PrognomiQ. PrognomiQ has raised $34M in total funding. Latest round: Series C. Based in San Mateo, CA.
Philip Ma is the CEO, President, and Founder of PrognomiQ, a company focused on developing and commercializing healthcare products for the early detection and treatment of cancer and other complex diseases. PrognomiQ spun out of Seer, where Ma was previously Chief Business Officer, President, and Founder. Before Seer, he held a role as Vice-President of Digital Health Technology and Data Sciences at Biogen and was a Senior Partner at McKinsey & Company. He earned a Ph.D. in biology from MIT, an M.Phil. in economics from Oxford University, and an A.B. in biochemistry from Harvard University.
Full founder directory · Investor directory · Company funding database · Fundraising library